Back to Search
DAVID WALCHER, MD
MD
Internal Medicine Physician
NPI: 1972509255Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
25762(MN)
Research & Publications (17)
Advanced glycation end products and C-peptide-modulators in diabetic vasculopathy and atherogenesis.
PMID 19347338·Semin Immunopathol·2009
6-review
Signalling processes involved in C-peptide-induced chemotaxis of CD4-positive lymphocytes.
PMID 19373435·Cell Mol Life Sci·2009
8-other
Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease.
PMID 18942491·Clin Lab·2008
8-other
C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?
PMID 18401446·Exp Diabetes Res·2008
6-review
Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma.
PMID 18158351·Hypertension·2008
8-other
Vascular effects of PPARgamma activators - from bench to bedside.
PMID 17637478·Prog Lipid Res·2007
6-review
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.
PMID 16410460·Arterioscler Thromb Vasc Biol·2006
2-rct
C-Peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2.
PMID 17068290·Circ Res·2006
7-preclinical
LXR activation reduces proinflammatory cytokine expression in human CD4-positive lymphocytes.
PMID 16484597·Arterioscler Thromb Vasc Biol·2006
8-other
Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients.
PMID 16246947·Circulation·2005
2-rct
Rapid effects of rosiglitazone treatment on endothelial function and inflammatory biomarkers.
PMID 16002742·Arterioscler Thromb Vasc Biol·2005
3-trial
Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control: results from the pioneer study.
PMID 15963388·J Am Coll Cardiol·2005
3-trial
C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro.
PMID 14707040·Arterioscler Thromb Vasc Biol·2004
8-other
Insulin resistance and cardiovascular disease: the role of PPARgamma activators beyond their anti-diabetic action.
PMID 16302645·Diab Vasc Dis Res·2004
6-review
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products.
PMID 15448098·Diabetes·2004
8-other
C-peptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase.
PMID 15220188·Diabetes·2004
8-other
Inhibition of MMP-9 expression by PPARgamma activators in human bronchial epithelial cells.
PMID 12947137·Thorax·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6545 FRANCE AVENUE SOUTH, SUITE 510
EDINA, MN 55435 - Phone
- (952) 927-7079
Quick Facts
- NPI
- 1972509255
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 17
Are you this provider?
Claim Your Profile